December 3, 2008
| Bio-IT World > Drug Discovery
Drug Discovery


Change page: < >  |  Displaying page 1 of 258, items 1 to 10 of 2578.

IBM CEO Survey Shows Hunger for Change in Life Sciences

Bio-IT World | “Change” is not merely a common refrain on the presidential election campaign trail. It’s also what dozens of life science CEOs are hankering for, according to preliminary findings from the latest IBM CEO survey. Michael Svinte, IBM’s VP Global Innovation and Information-Based Medicine, shared some of those findings with Bio-IT World at a briefing during the Drug Industry Association conference (DIA) this week in Boston.

NIH Laptop Theft: How Safe Is Your Data? Bio-IT World | A laptop stolen from the NIH included seven years’ worth of clinical trial data, including names, medical diagnoses, and details of the patients' heart scans.

Applied Biosystems and the $60,000 Human Genome Bio-IT World | Just weeks after Illumina announced it had cracked the $100,000 threshold for sequencing a human genome, Applied Biosystems has sequenced a complete human genome sample using its new SOLiD next-generation sequencing platform, reportedly for less than $60,000.

Helicos' Kristen Stoops on Next-Generation Data Management Bio-IT World | Interview with Kristen Stoops, Helicos' director of bioinformatics, who is building a federation of IT vendors to identify best practices that will help users manage torrents of data.

Grand Challenges Program Seeks Proposals for Global Health Breakthroughs Bio-IT World | The Bill & Melinda Gates Foundation has issued a call for proposals for its Grand Challenges in Global Health program.

MIT Launches Interdisciplinary Cancer Center Bio-IT World | The David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology opened today in Cambridge, and will replace the previous MIT Center for Cancer Research.

Helicos Ships First Instrument to Expression Analysis Bio-IT World | Helicos BioSciences announced today that it has shipped the first ever single-molecule sequencing instrument – the HeliScope – to Expression Analysis, a contract genomic services company.

Flawed Embryos Seen as Source for Stem Cells

Alzheimer's Research Target May Be a Dead End

Scientists Advance in Effort to Create Synthetic Organism

White Papers & Special Reports

Coupa white paper 92
10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



SGI BriefingON image
High-Performance Computing in Life Science & Education
Sponsored by SGI and Intel
The varied collection of Bio-IT World articles and insights assembled in this BriefingON examine key trends in HPC infrastructure and how researchers are putting their best computational resources to use. Provided here are stories and lessons around the effective use of high performance computing in life science. Download the BriefingON.


Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 




For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.